CA2286357A1 - Antacid and papain combination - Google Patents

Antacid and papain combination Download PDF

Info

Publication number
CA2286357A1
CA2286357A1 CA002286357A CA2286357A CA2286357A1 CA 2286357 A1 CA2286357 A1 CA 2286357A1 CA 002286357 A CA002286357 A CA 002286357A CA 2286357 A CA2286357 A CA 2286357A CA 2286357 A1 CA2286357 A1 CA 2286357A1
Authority
CA
Canada
Prior art keywords
dose
composition
amount
compositions
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002286357A
Other languages
English (en)
French (fr)
Inventor
Constantine Georgiades
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2286357A1 publication Critical patent/CA2286357A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22002—Papain (3.4.22.2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
CA002286357A 1997-07-15 1998-07-08 Antacid and papain combination Abandoned CA2286357A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5254397P 1997-07-15 1997-07-15
US60/052,543 1997-07-15
PCT/US1998/014233 WO1999003486A1 (en) 1997-07-15 1998-07-08 Antacid and papain combination

Publications (1)

Publication Number Publication Date
CA2286357A1 true CA2286357A1 (en) 1999-01-28

Family

ID=21978305

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002286357A Abandoned CA2286357A1 (en) 1997-07-15 1998-07-08 Antacid and papain combination

Country Status (9)

Country Link
EP (1) EP1001796A1 (es)
JP (1) JP2002509539A (es)
AR (1) AR016514A1 (es)
AU (1) AU8296898A (es)
BR (1) BR9809419A (es)
CA (1) CA2286357A1 (es)
PE (1) PE102699A1 (es)
WO (1) WO1999003486A1 (es)
ZA (1) ZA986247B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000083619A (ja) * 1998-07-15 2000-03-28 Oju Seiyaku:Kk 健康食品とその製造方法
BRPI0006503B1 (pt) * 2000-02-04 2017-05-09 Biolab Sanus Farmacêutica Ltda composição em forma de gel, creme, aerosol, spray, líquida e liofilizada de substância carreadora de produtos à base de papaína
WO2007010547A1 (en) * 2004-11-04 2007-01-25 Abhoy Sankar Arora A phyto-medicine and a process for the preparation thereof
GB0820846D0 (en) * 2008-11-14 2008-12-24 Carson John W Improved proteinaceous digestates
IT201700090582A1 (it) * 2017-08-04 2019-02-04 Neilos S R L Composizione per l’uso nella prevenzione e/o nel trattamento di disturbi gastrici o gastroesofagei.

Also Published As

Publication number Publication date
ZA986247B (en) 1999-02-05
WO1999003486A1 (en) 1999-01-28
AU8296898A (en) 1999-02-10
PE102699A1 (es) 1999-11-05
JP2002509539A (ja) 2002-03-26
AR016514A1 (es) 2001-07-25
BR9809419A (pt) 2000-06-13
EP1001796A1 (en) 2000-05-24

Similar Documents

Publication Publication Date Title
WO1997018796A1 (en) Fast-melt solid dosage form and method of making same
EP0862415A1 (en) Fast-melt solid dosage form and method of making same
NZ529779A (en) Pharmaceutical formulation consisting of a plant dry extract with a calcium coating
JP2016166220A (ja) 胃酸を中和する固形医薬組成物
KR100238565B1 (ko) 상부 위장관 통증을 치료하기 위한 섭취가능한 약학적 조성물
AU1674692A (en) Chewable antacid compositions
AU2006270162B2 (en) A powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis
Ericsson Monofluorophosphate physiology: general considerations
CA2286357A1 (en) Antacid and papain combination
TW201946612A (zh) 醫藥組合物
US20230000899A1 (en) Alginate, polylysine, and seed preservative nutritional product and digestive aid
CA2171829A1 (en) Oral water soluble pharmaceutical compositions containing estrone derivative and calcium salt
RU2497527C2 (ru) Фармацевтическая композиция для лечения расстройств, включающих раздражение желудочно-кишечного тракта
MXPA99008920A (es) Combinacion de papaina y un antiacido
WO2019026047A1 (en) COMPOSITION FOR USE IN THE PREVENTION AND / OR TREATMENT OF GASTRIAL OR GASTRO-ESOPHAGEAL DISEASES
EP0715520B1 (en) Use of a suspension based on sucralphate gel as antacid
WO2010108494A1 (en) Dayspepsia treatment with alginate
ES2274550T3 (es) Procedimientos y composiciones para prevenir y tratar ardor de estomago.
WO1992015206A1 (en) A pulverous composition, a method for preparing it, and a method for improving the taste of the composition
WO2010092415A1 (en) Combination of hesperidin and antacids in the treatment of gastro-esophageal reflux disease (gerd)
KR100876326B1 (ko) 소화 촉진 효과가 있는 조성물
Ushkalova Why are antacids prescribed in an hour. Features of the use of antacids: list and classification
WO1997040843A2 (en) Method of preventing gastrointestinal upset
Ushkalova What drugs are antacids? Antacids: principle of action, examples, indications for use
KR19990056904A (ko) 숙취 치료용 조성물

Legal Events

Date Code Title Description
FZDE Discontinued